» Articles » PMID: 38261591

The Nonlinear Association Between Triglyceride Glucose-body Mass Index and Femoral Neck BMD in Nondiabetic Elderly Men: NHANES 2005-March 2020

Overview
Journal PLoS One
Date 2024 Jan 23
PMID 38261591
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The triglyceride glucose-body mass index (TyG-BMI) has been considered a surrogate marker for assessing insulin resistance. We aimed to correlate the TyG-BMI, triglyceride glucose combined with body mass index, with femoral neck bone mineral density (FN BMD) in non-diabetic elderly men.

Methods: Using data from the National Health and Nutrition Examination Survey (NHANES) database, totally, 1182 eligible men aged ≥ 50 years without diabetes were included in the current study. Smoothed curves were obtained by a two-piecewise linear regression model and the threshold effects were explored by using a smoothing function.

Results: TyG-BMI was positive related with and FN BMD with or without adjustment for confounders. However, no typical dose-dependent positive association between TyG-BMI and FN BMD was observed across the TyG-BMI tertiles, indicating a non-linear association. Further analysis by the weighted two-piecewise linear regression model and recursive algorithm suggested that per SD increase in TyG-BMI increased FN BMD by 0.266 gm/cm2 when TyG-BMI lower than 168.20. However, when TyG-BMI is higher than 168.20, FN BMD only increased 0.046 gm/cm2 for per SD increase of TyG-BMI after fully adjustment (OR = 11.258, 95%CI: 6.034, 16.481). Moreover, subgroup analyses showed that higher TyG-BMI levels were related to elevated FN BMD in all groups, suggesting the consistency of the positive association within these stratas.

Conclusions: This study demonstrated that TyG-BMI is positively associated with FN BMD in a nonlinear fashion among elderly men without diabetes, which may be a reliable marker for the early identification of individuals with lower FN BMD.

Citing Articles

Insulin Resistance and Bone Mineral Density: A Comprehensive Examination Using UK Biobank Data.

Hung Y, Yu T, Alizargar J Healthcare (Basel). 2025; 12(24.

PMID: 39765929 PMC: 11727659. DOI: 10.3390/healthcare12242502.


A systematic review of the association between insulin resistance surrogate indices and bone mineral density.

Shirinezhad A, Azarboo A, Ghaseminejad-Raeini A, Kanaani Nejad F, Zareshahi N, Amiri S Front Endocrinol (Lausanne). 2025; 15:1499479.

PMID: 39744182 PMC: 11688183. DOI: 10.3389/fendo.2024.1499479.


Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity.

Tao J, Li H, Wang H, Tan J, Yang X Osteoporos Int. 2024; 35(12):2087-2098.

PMID: 39136721 DOI: 10.1007/s00198-024-07217-y.


Association between surrogate marker of insulin resistance and bone mineral density in US adults without diabetes.

Tian C, Liu J, Ma M, Wang S, Zhang Y, Feng Z Arch Osteoporos. 2024; 19(1):42.

PMID: 38796579 DOI: 10.1007/s11657-024-01395-2.

References
1.
Loke S, Chang H, Li W . Association between metabolic syndrome and bone mineral density in a Taiwanese elderly population. J Bone Miner Metab. 2017; 36(2):200-208. DOI: 10.1007/s00774-017-0826-7. View

2.
Nguyen N, Center J, Eisman J, Nguyen T . Bone loss, weight loss, and weight fluctuation predict mortality risk in elderly men and women. J Bone Miner Res. 2007; 22(8):1147-54. DOI: 10.1359/jbmr.070412. View

3.
Kang B, Yang Y, Lee E, Yang H, Kim H, Lim S . Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents. Int J Obes (Lond). 2017; 41(5):789-792. DOI: 10.1038/ijo.2017.14. View

4.
Borgstrom F, Karlsson L, Ortsater G, Norton N, Halbout P, Cooper C . Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020; 15(1):59. PMC: 7166207. DOI: 10.1007/s11657-020-0706-y. View

5.
Kazemi M, Jarrett B, Parry S, Thalacker-Mercer A, Hoeger K, Spandorfer S . Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study. J Clin Endocrinol Metab. 2020; 105(9). PMC: 7418445. DOI: 10.1210/clinem/dgaa426. View